S. 3812: Workplace Overdose Reversal Kits to Save Lives Act

This bill, titled the Workplace Overdose Reversal Kits to Save Lives Act or the WORK to Save Lives Act, aims to address the issue of opioid overdoses in the workplace by introducing measures related to the acquisition and use of opioid overdose reversal medication.

Key Provisions

Non-Mandatory Guidance for Employers

Within 270 days of the bill's enactment, the Secretary of Labor, through the Occupational Safety and Health Administration (OSHA), will provide non-mandatory guidance for employers on two main topics:

• How to acquire and maintain opioid overdose reversal medication.
• How to train employees annually on the proper usage of this medication.

The guidance is intended to help employers consider adopting these practices voluntarily.

Mandatory Regulations for Federal Agencies

In contrast, within the same 270-day period, the Secretary of Labor must issue mandatory regulations that require each Federal agency to:

• Acquire and maintain opioid overdose reversal medication.
• Train employees annually on the usage of such medication.

This means that federal agencies will be obligated to have these measures in place to address potential opioid overdose situations.

Definitions

For the purposes of this bill:

• An employer is defined in accordance with the Occupational Safety and Health Act of 1970, excluding the United States Postal Service.
• A Federal agency includes any agency or instrumentality of the Federal Government, such as the Veterans Health Administration.

Overall Goals

The primary objective of this legislation is to enhance workplace safety by ensuring that both employers and federal agencies are prepared to respond to opioid overdoses effectively. The recommendations for private employers aim to promote the voluntary adoption of overdose prevention practices, while the mandatory requirements for federal agencies aim to establish a standard response protocol across the federal system.

Relevant Companies

None found